Your session is about to expire
← Back to Search
Stem Cell Therapy for Lung Disease (ADcSVF-COPD Trial)
ADcSVF-COPD Trial Summary
This trial is studying whether treating COPD with autologous (from the patient) derived cells that are expanded and concentrated is safe and can improve lung function.
ADcSVF-COPD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowADcSVF-COPD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ADcSVF-COPD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have Alpha-1 Antitrypsin Deficiency.I am unable or unwilling to understand or sign a consent form.I have been diagnosed with moderate to severe COPD.I am on long-term medication to suppress my immune system or for chemotherapy.My COPD is moderate to very severe.I am not pregnant or breastfeeding.You have other health problems that make it likely you will live for less than 3 months.I have a history of Hepatitis B or C, but not A.
- Group 1: Lipoaspiration Arm 1
- Group 2: AD-cSVF Arm 2
- Group 3: Normal Saline IV Arm 3
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it feasible for me to partake in this research?
"To be considered for this research, participants must have a pre-existing lung disorder and fall between the ages of eighteen to eighty. Presently, there is an aim to recruit one hundred patients in total."
Is there an ongoing call for participants in this experiment?
"Contrary to what is listed on clinicaltrials.gov, this trial has now closed its recruitment process as of August 1st 2022. It originally opened for enrolment on October 1st 2016 and had a total of 283 other studies recruiting participants at the same time."
Does the eligibility criterion for this trial specify an age limit of 40 years or younger?
"This medical trial is open to individuals aged 18-80 years old. For those younger than 18 or older than 65, there are 26 and 270 respective studies available for them to consider participating in."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger